Telomir Pharmaceuticals, Inc. Financial Overview
Telomir Pharmaceuticals, Inc.'s market cap is currently $48.13M. The company's EPS TTM is $-0.574; its P/E ratio is -3.75; Telomir Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.